Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic adherence and health literacy: a perfect match in dyslipidemic patients.

Minerva medicaยท2026
Same author

Lipid lowering therapy in Tangier disease: what is the best association?

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosisยท2026
Same author

Lipoprotein apheresis as rescue therapy in lipoprotein glomerulopathy: The role of plasmatic extracellular vesicle removal.

Journal of clinical lipidologyยท2026
Same author

Lipoprotein apheresis in the era of new lipid-lowering therapies.

European heart journalยท2026
Same author

Severe familial hypercholesterolemia and pregnancy: handle with care.

Nutrition, metabolism, and cardiovascular diseases : NMCDยท2026
Same author

Maximising LDL-Cholesterol Reduction: Integrating Inclisiran With Lipid-Lowering Strategies.

Heart, lung & circulationยท2026

Related Experiment Video

Updated: Jun 22, 2026

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction
03:42

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

[Heart without HDL.Tangier disease].

Maria Rita Puntoni1, Federico Bigazzi, Francesco Sbrana

  • 1Scuola Superiore Sant'Anna, Pisa.

Recenti Progressi in Medicina
|June 27, 2009
PubMed
Summary

This case study highlights Tangier disease, a rare genetic disorder causing severe lipid abnormalities. It emphasizes the link between extreme HDL deficiency and early-onset cardiovascular disease, requiring interventions like bypass surgery.

More Related Videos

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Related Experiment Videos

Last Updated: Jun 22, 2026

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction
03:42

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Area of Science:

  • Lipidology
  • Genetics
  • Cardiovascular Medicine

Background:

  • Tangier disease is a rare autosomal recessive disorder characterized by defects in lipid metabolism.
  • It leads to severely deficient high-density lipoprotein (HDL) and apolipoprotein A-I (apoA-I) levels.
  • This deficiency results from mutations in the ABCA1 gene, affecting cholesterol efflux.

Observation:

  • A 37-year-old male presented with profound dyslipidemia, including extremely low HDL (4 mg/dL) and apoA-I (3.9 mg/dL) levels.
  • Physical examination revealed characteristic orange tonsils and hepatosplenomegaly.
  • Hematologic findings included thrombocytopenia and stomatocytes.

Findings:

  • The patient exhibited severe coronary atherosclerosis, necessitating percutaneous revascularization.
  • He later developed restenosis, requiring coronary artery bypass grafting (CABG).
  • Diagnosis of Tangier disease was confirmed by the pathognomonic triad: HDL deficiency, low cholesterol with normal triglycerides, and orange tonsils.

Implications:

  • This case underscores the critical role of HDL in cardiovascular health and highlights the severe early-onset atherosclerosis associated with Tangier disease.
  • Early diagnosis and aggressive management of cardiovascular risk factors are crucial in patients with Tangier disease.
  • Understanding the genetic basis of Tangier disease can inform therapeutic strategies for lipid disorders.